What happened during this study?
Each of the participants was in the study for up to just over 22 weeks. But, the
entire study took 15 months to finish.
The study started in April 2019 and ended in July 2020.
Some participants were still in the study when the COVID-19 pandemic began.
For these participants, some visits were done through phone calls rather than in
person.
The chart below shows what happened during this study.
Before the participants took study treatment
up to 3 visits
The study doctors: All participants:
checked the health of the participants to answered questionnaires about
make sure they could join the study their symptoms
did a physical exam and asked about did a 6-minute walk distance test, also
the participants’ medications and any called 6MWD
medical problems
took blood and urine samples
Some participants:
checked the participants’ heart health wore a device that measured their
using an electrocardiogram, also called activity levels
an ECG
This part of the study took 2 weeks
While the participants took study treatment
2 visits and 1 phone call
The study doctors: All participants:
did a physical exam and asked about took dapagliflozin or placebo once a day
the participants’ medications and
any medical problems
took blood and urine samples answered questionnaires about
their symptoms
did the 6MWD test
Some participants:
wore a device that measured their
activity levels
This part of the study took 16 weeks
8 | Clinical Study Results